Experiments have revealed that small molecule agents, such as demethylzeylasteral, can significantly downregulate PD‐L1 expression in tumor cells and enhance the cytotoxic effect of T cells on tumor cells, potentially enhancing the efficacy of immunotherapy when used in conjunction with CTLA‐4 antibodies [44]. The gene discussed is CTLA4; the disease is neoplasm.